期刊文献+

^(99m)Tc标记depreotide的实验研究

Depreotide labeled by ^(99m)Tc
原文传递
导出
摘要 目的:采用直接标记法将99mTc标记depreotide,筛选depreotide的最佳标记条件,建立一种简便可靠的99mTc-depreotide制备方法。方法:采用直接标记99mTc的方法,在不同的pH值(5.0、6.0和7.0)缓冲溶液和不同的环境温度(15℃、37℃和50℃)条件下,对depreotide进行标记,以纸层析法测定计算标记率并通过比较分析筛选出最佳标记条件。结果:1)同一温度条件下,pH6.0实验组标记率高于pH5.0和pH7.0两实验组。在15℃条件下,pH5.0组和pH6.0组的标记率统计分析结果为t=9.232,P<0.001;pH6.0组与pH7.0组的t=9.533,P<0.001;在37℃条件下,pH5.0组与pH6.0组的t=4.121,P<0.01;pH7.0组与pH6.0组的t=6.207,P<0.001。2)随着反应温度由15℃逐渐升高到50℃,各pH实验组的标记率不同程度地下降。结论:99mTc直接标记depreotide,在低温(<15℃)和弱酸性环境下,肿瘤标志的标记率高,稳定性好。 OBJECTIVE:To establish a simple and reliable method of making 99mTc-depreotide by direct labeling. METHODS: Depreotide was labeled with 99mTc through a direct labeling method. By comparing the labeling efficiency in different pH(s) (5.0,6.0,7.0) and temperatures(15 ℃,37 ℃,50 ℃),the best labeling method was searched. RESULTS: 1)At the same temperatue,the labeling efficiency of the pH6.0 group was higher than that of the pH5.0 and pH7.0 groups. At the condition of 15 ℃,the labeling efficiency had a significant difference between the pH6.0 and pH5.0 groups or between the pH6.0 and pH7.0 groups (t=9.232 and 9.533,respectively,both P〈0.001). There was a similar result at 37 ℃(t=4.121 and 6.207,respectively,both P〈0.01). 2)The labeling efficiency of all the three different pH experiment groups reduced with the increasing temperature from 15 ℃ to 50 ℃ in this study. CONCLUSION: When depreotide is labeled with 99mTc,the temperature can not be too high(〈15 ℃) and the pH would be weak acid.
出处 《中华肿瘤防治杂志》 CAS 2009年第18期1368-1371,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 上海市卫生局科技发展基金(054035) 上海市科委基础重点项目(08JC1419700)
关键词 生长抑素 鍀-99m 地普奥肽 放射性核素 somatostatin 99mTc depreotide radionuclide
  • 相关文献

参考文献8

  • 1邢加强,张百江,杨国仁,高玉军,霍宗伟.肺癌生长抑素受体表达与其靶向显像的相关性研究[J].中华肿瘤防治杂志,2008,15(16):1240-1243. 被引量:3
  • 2Watt H L, Kharmate G, Kumar U. Biology of somatostatin in breast cancer[J]. Mol Cell Endocrinol,2008,286(1-2):251 261. 被引量:1
  • 3Okarvi S M. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer[J]. Cancer Treat Rev, 2008,34 (1): 13-26. 被引量:1
  • 4Shorr A F, Helman D L, Lettieri C J, et al. Depreotide scanning in sarcoidosis[J].A Pilot Study chest, 2004,126(4) : 1337-1343. 被引量:1
  • 5王秀娟,李险峰.生长抑素受体肿瘤显像的临床应用及研究进展[J].国际放射医学核医学杂志,2006,30(4):217-219. 被引量:3
  • 6Bieke V D, Eveline D, Klaus B, et al. Biodistribution and dosimetry of ^99mTc-Depreotide (P829) in patients suffering from breast carcinoma[J]. Cancer Biother Radiopharm, 2004, 19 (9) : 776-783. 被引量:1
  • 7Liu S. Bifunctional coupling agents for radiolabeling of biomole cules and target-specific delivery of metallic radionuclides[J]. Adv Drug Deliv Rev,2008,60(12):1347-1370. 被引量:1
  • 8Uehara, Y Arano, Ono M, et al. The integrity of the disulfide bond in a cyclic somatostatin analog during ^99mTc complexation reactions[J]. Nucl reed boil,1999,26(8):883-890. 被引量:1

二级参考文献22

  • 1谢红,孙丽华,乔岩,谷伟,王自正,王峰.^(99m)Tc-Sandostatin生长抑素受体显像在肺癌诊治中的临床意义[J].医学研究生学报,2004,17(12):1088-1089. 被引量:6
  • 2王峰,王自正,姚薇萱,陈正国,谢红,徐崇英,孟庆乐,曹艳.^(99)Tc^m-生长抑素受体显像对肺癌的诊断价值[J].中华结核和呼吸杂志,2005,28(4):218-220. 被引量:12
  • 3彭卫军,刘士远.肺癌筛查方法及其评价[J].中华肿瘤防治杂志,2006,13(17). 被引量:12
  • 4Lowe V, Fletcher J, Gobar L, et al. Prospective investigation of positron emission tomography in lung nodules[J]. J Clin Oncol, 1998, 16:1075-1084. 被引量:1
  • 5Tang C, Biemond I, Verspaget H W, et al. Expression of soma tostatin Receptor sinhuman pancreatic tumor [J]. Pancreas, 1998, 17:80-84. 被引量:1
  • 6BlumJ E, Handmarker H, Rinne N A. The utility of a somatostatin Type receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules [J]. Chest, 1999, 115(1):224-232. 被引量:1
  • 7Vitgolini I, Traub T, Nowmy C, et al. Experience with indium- 111 and yttrium-90-1abeled Somatastatin analogs [J]. Curr Pharm Des, 2002, 8 (20):1781. 被引量:1
  • 8Virgolini I, Traub T, Novotny C, et al. Experience with indi um 111 and yttrium-90-1abeled somatostatin analogs [J]. Curr Pharm Des, 2002, 8(20) :1781-807. 被引量:1
  • 9Kwekkeboom D J, Krenning E P, Bakker W H, et al. Radioiodi nated somatostatin analog scintigraphy in small cell lung cancer [J]. J Nucl Med, 1991, 32(10):1845-1848. 被引量:1
  • 10Bohuslavizki K H. Somatostatin receptor imaging : current status and future perspectives[J]. J Nucl Med, 2001, 42(7) : 1057-1058. 被引量:1

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部